Literature DB >> 20788266

Drug Treatment of Hypertension.

.   

Abstract

Entities:  

Year:  1954        PMID: 20788266      PMCID: PMC2085308     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  13 in total

1.  A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension.

Authors:  A P SHAPIRO; A GROLLMAN
Journal:  Circulation       Date:  1953-08       Impact factor: 29.690

2.  The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine.

Authors:  E D FREIS; J C ROSE; T F HIGGINS; F A FINNERTY; R T KELLEY; E A PARTENOPE
Journal:  Circulation       Date:  1953-08       Impact factor: 29.690

3.  Headache and hypertension.

Authors:  I M STEWART
Journal:  Lancet       Date:  1953-06-27       Impact factor: 79.321

4.  Parenteral hexamethonium in hypertension.

Authors:  B MORRISON
Journal:  Br Med J       Date:  1953-06-13

5.  The use of Rauwolfia serpentina in hypertensive patients.

Authors:  R W WILKINS; W E JUDSON
Journal:  N Engl J Med       Date:  1953-01-08       Impact factor: 91.245

6.  Hypertension-I.

Authors:  R Platt
Journal:  Br Med J       Date:  1950-04-22

7.  Dihydrogenated alkaloids of ergot in the investigation and treatment of diastolic hypertension.

Authors:  D F GIBBS
Journal:  Br Heart J       Date:  1952-01

8.  "Medical sympathectomy" in hypertension; a clinical study of methonium compounds.

Authors:  R TURNER
Journal:  Lancet       Date:  1950-09-02       Impact factor: 79.321

9.  The treatment of high blood pressure with hexamethonium iodide.

Authors:  P A RESTALL; F H SMIRK
Journal:  N Z Med J       Date:  1950-06

10.  Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A).

Authors:  F H SMIRK
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.